Albumin for patients with acute large vessel occlusive stroke undergoing endovascular therapy-2 (ARISE-2): protocol for a randomised controlled trial
Zilin Xu, Yuanyuan Liu, Yanbo Huang, Yuzhang Bei, Yong He, Yanling Li, Hao Wang, Lingling Meng, Le Gao, Yan Li, Yuhang Cao, Lan Liu · 2026
Read Albumin for patients with acute large vessel occlusive stroke undergoing endovascular therapy-2 (ARISE-2): protocol for a randomised controlled trial by Zilin Xu, Yuanyuan Liu, Yanbo Huang, Yuzhang Bei, Yong He, Yanling Li, Hao Wang, Lingling Meng, Le Gao, Yan Li, Yuhang Cao, Lan Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13636092.txt.
Description
Zilin Xu and fourteen colleagues set out the protocol for a randomized trial testing albumin as an add-on treatment for major stroke. Threading a catheter to pull clots from blocked brain arteries is now standard care, yet nearly half of patients stay dependent afterward. Albumin, a blood protein, protected brains in animal studies and might shield tissue as flow returns. This multicenter trial assigns patients with front-circulation blockages to vessel treatment alone or with albumin.
The albumin group receives a dose within an hour of assignment, repeated daily for three more days. The target is about twelve hundred participants, with a built-in halfway review that may raise the total. Recovery judges at ninety days will not know who received what. Success means living independently or returning to one's prior level. The authors expect a clear answer on whether albumin earns a place beside clot removal.
Catalog record
| CREATOR | Zilin Xu, Yuanyuan Liu, Yanbo Huang, Yuzhang Bei, Yong He, Yanling Li, Hao Wang, Lingling Meng, Le Gao, Yan Li, Yuhang Cao, Lan Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |